9103U |
Alfentanil Screen, Urine |
9109B |
Atropine Screen, Blood |
9109SP |
Atropine Screen, Serum/Plasma |
9109U |
Atropine Screen, Urine |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam and Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9165B |
Ephedrine Screen, Blood |
9176B |
Fentanyl and Metabolite Screen, Blood |
9176FL |
Fentanyl and Metabolite Screen, Fluid |
9176SP |
Fentanyl and Metabolite Screen, Serum/Plasma |
9176TI |
Fentanyl and Metabolite Screen, Tissue |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9193U |
Methylphenidate and Metabolite Screen, Urine |
9196SP |
Meclizine Screen, Serum/Plasma |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9215B |
Nitrazepam and Metabolite Screen, Blood |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9237U |
Phenylpropanolamine Screen, Urine |
9247B |
Propranolol Screen, Blood |
9247SP |
Propranolol Screen, Serum/Plasma |
9248B |
Pseudoephedrine Screen, Blood |
9248SP |
Pseudoephedrine Screen, Serum/Plasma |
9248U |
Pseudoephedrine Screen, Urine |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9254B |
Quinine/Quinidine Screen, Blood |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9264B |
Sufentanil Screen, Blood |
9264U |
Sufentanil Screen, Urine |
9288B |
Tramadol and Metabolite Screen, Blood |
9288FL |
Tramadol and Metabolite Screen, Fluid |
9288SP |
Tramadol and Metabolite Screen, Serum/Plasma |
9291H |
Fentanyl Screen, Hair |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9416B |
Phenobarbital Screen, Blood |
9447B |
Venlafaxine and Metabolite Screen, Blood |
9447U |
Venlafaxine and Metabolite Screen, Urine |